| Date Filed | Type | Description |
| 05/11/2023 |
4
| Patel Gautam (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 11/29/2022 |
4
| Patel Gautam (Director) has filed a Form 4 on Spectrum Brands Holdings, Inc.|
Txns:
| Granted 5,020 shares
@ $0 |
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Patel Gautam (Director) has filed a Form 4 on Spectrum Brands Holdings, Inc.|
Txns:
| Granted 3,533 shares
@ $0 |
|
| 10/14/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2020 |
4
| Patel Gautam (10% Owner) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 46,218 restricted stock units
@ $0
Exercised 6,459 restricted stock units
@ $0 |
|
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
SC 13D/A
| Patel Gautam reports a 19.2% stake in Amneal Pharmaceuticals, Inc. |
| 05/08/2019 |
4
| Patel Gautam (10% Owner) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 28,044 options
@ $14.05, valued at
$394k
Granted 6,459 restricted stock units
@ $0
Exercised 6,107 restricted stock units
@ $0 |
|
| 07/09/2018 |
SC 13D
| Patel Gautam reports a 20.9% stake in Amneal Pharmaceuticals, Inc. |
| 07/09/2018 |
4
| Patel Gautam (10% Owner) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Acquired 30,384,769 shares
@ $0
Acquired 30,384,769 units
@ $0 |
|
| 05/09/2018 |
4
| Patel Gautam (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 24,977 options
@ $15.01, valued at
$374.9k
Granted 6,107 restricted stock units
@ $0 |
|
| 05/09/2018 |
3
| Patel Gautam (Director) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |